Hasil Pencarian - Jolanda M De Vries

Perbaiki Hasil
  1. 1
    Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune Function

    Dendritic Cells Require PINK1-Mediated Phosphorylation of BCKDE1α to Promote Fatty Acid Oxidation for Immune Function oleh Farhan Basit, I. Jolanda M. de Vries, I. Jolanda M. de Vries

    Diterbitkan 2019-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response

    Human Dendritic Cell Subsets Undergo Distinct Metabolic Reprogramming for Immune Response oleh Farhan Basit, Till Mathan, David Sancho, I. Jolanda M. de Vries, I. Jolanda M. de Vries

    Diterbitkan 2018-11-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation

    Primary Human Blood Dendritic Cells for Cancer Immunotherapy—Tailoring the Immune Response by Dendritic Cell Maturation oleh Simone P. Sittig, I. Jolanda M. de Vries, Gerty Schreibelt

    Diterbitkan 2015-12-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity

    Attacking Tumors From All Sides: Personalized Multiplex Vaccines to Tackle Intratumor Heterogeneity oleh Felix L. Fennemann, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Carl G. Figdor, Carl G. Figdor, Carl G. Figdor, Martijn Verdoes, Martijn Verdoes

    Diterbitkan 2019-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer

    The Therapeutic Potential of Tackling Tumor-Induced Dendritic Cell Dysfunction in Colorectal Cancer oleh Beatriz Subtil, Alessandra Cambi, Daniele V. F. Tauriello, I. Jolanda M. de Vries

    Diterbitkan 2021-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage

    Subsets of CD1c+ DCs: Dendritic Cell Versus Monocyte Lineage oleh Lukas Heger, Thomas P. Hofer, Venetia Bigley, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Marc Dalod, Diana Dudziak, Diana Dudziak, Diana Dudziak, Diana Dudziak, Loems Ziegler-Heitbrock

    Diterbitkan 2020-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma

    LDH Isotyping for Checkpoint Inhibitor Response Prediction in Patients with Metastatic Melanoma oleh Sandra van Wilpe, Sofie H. Tolmeijer, I. Jolanda M. de Vries, Rutger H. T. Koornstra, Niven Mehra

    Diterbitkan 2021-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists

    Tailored PGE2 Immunomodulation of moDCs by Nano-Encapsulated EP2/EP4 Antagonists oleh Johanna Bödder, Leanne M. Kok, Jonathan A. Fauerbach, Georgina Flórez-Grau, I. Jolanda M. de Vries

    Diterbitkan 2023-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  9. 9
    Immunotherapy for prostate cancer: Lessons from responses to tumor-associated antigens

    Immunotherapy for prostate cancer: Lessons from responses to tumor-associated antigens oleh Harm eWestdorp, Harm eWestdorp, Annette E. Skold, Berit A. Snijer, Sebastian eFranik, Sasja F. Mulder, Pierre Paul Major, Ronan eFoley, Winald R. Gerritsen, I. Jolanda M. de Vries, I. Jolanda M. de Vries

    Diterbitkan 2014-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  10. 10
    Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer

    Harnessing the cDC1-NK Cross-Talk in the Tumor Microenvironment to Battle Cancer oleh Johanna Bödder, Tasmin Zahan, Rianne van Slooten, Gerty Schreibelt, I. Jolanda M. de Vries, Georgina Flórez-Grau

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  11. 11
    The nature of activatory and tolerogenic dendritic cell-derived signal II

    The nature of activatory and tolerogenic dendritic cell-derived signal II oleh Ghaith eBakdash, Simone Patricia Sittig, Tjeerd evan Dijk, Carl G. Figdor, I. Jolanda M. de Vries

    Diterbitkan 2013-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  12. 12
    Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG

    Immune Curbing of Cancer Stem Cells by CTLs Directed to NANOG oleh Christina Wefers, Christina Wefers, Gerty Schreibelt, Leon F. A. G. Massuger, I. Jolanda M. de Vries, Ruurd Torensma

    Diterbitkan 2018-06-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  13. 13
    EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells

    EP2 and EP4 blockade prevents tumor-induced suppressive features in human monocytic myeloid-derived suppressor cells oleh Jorge Cuenca-Escalona, Beatriz Subtil, Alba Garcia-Perez, Alessandra Cambi, I. Jolanda M. de Vries, Georgina Flórez-Grau

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  14. 14
    STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics

    STAT Family Protein Expression and Phosphorylation State during moDC Development Is Altered by Platinum-Based Chemotherapeutics oleh Nienke de Haas, Coco de Koning, Stefania di Blasio, Georgina Flórez-Grau, I. Jolanda M. de Vries, Stanleyson V. Hato

    Diterbitkan 2019-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  15. 15
    A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery

    A tipping point in cancer-immune dynamics leads to divergent immunotherapy responses and hampers biomarker discovery oleh Winald R Gerritsen, Johannes Textor, Niven Mehra, Jeroen H A Creemers, W Joost Lesterhuis, Carl G Figdor, I Jolanda M de Vries

    Diterbitkan 2021-05-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  16. 16
    A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets

    A Comparative Study of the T Cell Stimulatory and Polarizing Capacity of Human Primary Blood Dendritic Cell Subsets oleh Simone P. Sittig, Ghaith Bakdash, Jorieke Weiden, Annette E. Sköld, Jurjen Tel, Carl G. Figdor, I. Jolanda M. de Vries, Gerty Schreibelt

    Diterbitkan 2016-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  17. 17
    PTEN Hamartoma Tumor Syndrome and Immune Dysregulation

    PTEN Hamartoma Tumor Syndrome and Immune Dysregulation oleh Marc Eissing, Lise Ripken, Gerty Schreibelt, Harm Westdorp, Marjolijn Ligtenberg, Romana Netea-Maier, Mihai G. Netea, I. Jolanda M. de Vries, Nicoline Hoogerbrugge

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  18. 18
    In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome

    In silico cancer immunotherapy trials uncover the consequences of therapy-specific response patterns for clinical trial design and outcome oleh Jeroen H. A. Creemers, Ankur Ankan, Kit C. B. Roes, Gijs Schröder, Niven Mehra, Carl G. Figdor, I. Jolanda M. de Vries, Johannes Textor

    Diterbitkan 2023-04-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  19. 19
    An altered gp100 peptide ligand with decreased binding by TCR and CD8alpha dissects T cell cytotoxicity from production of cytokines and activation of NFAT

    An altered gp100 peptide ligand with decreased binding by TCR and CD8alpha dissects T cell cytotoxicity from production of cytokines and activation of NFAT oleh Niels eSchaft, Niels eSchaft, miriam eCoccoris, Joost eDrexhage, Christiaan eKnoop, Jolanda M de Vries, Gosse J Adema, Reno eDebets

    Diterbitkan 2013-09-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  20. 20
    High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer

    High Health-Related Quality of Life During Dendritic Cell Vaccination Therapy in Patients With Castration-Resistant Prostate Cancer oleh Harm Westdorp, Harm Westdorp, Jeroen H. A. Creemers, Jeroen H. A. Creemers, Inge M. van Oort, Niven Mehra, Niven Mehra, Simone M. Hins-de Bree, Carl G. Figdor, Carl G. Figdor, J. Alfred Witjes, Gerty Schreibelt, I. Jolanda M. de Vries, I. Jolanda M. de Vries, Winald R. Gerritsen, Winald R. Gerritsen, Petronella B. Ottevanger

    Diterbitkan 2020-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: